NYSCF Speaks at the FDA
NYSCF Senior Research Fellow Dieter Egli presented his research on a technique to prevent the transmission of mitochondrial diseases to the Food and Drug Administration (FDA) Advisory Committee meeting on Cellular, Tissue and Gene Therapies. The meeting, held in Gaithersburg, Maryland, aimed to give recommendations to the FDA on whether to approve human clinical trials for techniques to prevent this group of devastating, and often fatal, diseases and other infertility treatments.
Dr. Egli's research and discovery that transfering the nucleus of an egg from a woman with mitochondrial disease into a donor egg allows her to have her own genetic children without the threat of mitochondrial disease was recognized as a top scientific breakthrough in 2012.
Read more about the meeting in the Washington Post >>